Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Type 1 Diabetes”

Showing 20 of 0 results

Not applicableLooking for participantsNCT05899166
What this trial is testing

Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Boston Children's Hospital 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT05743244
What this trial is testing

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 78
Post-approval studies (Phase 4)UnknownNCT03032354
What this trial is testing

Probiotics in Newly Recognized Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Medical University of Warsaw 96
Not applicableLooking for participantsNCT07483879
What this trial is testing

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusDiabetic Ketoacidosis
Aristotle University Of Thessaloniki 45
Post-approval studies (Phase 4)Study completedNCT04157738
What this trial is testing

Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

Who this might be right for
Diabetes MellitusType 1 Diabetes
Emory University 24
Not applicableLooking for participantsNCT01055093
What this trial is testing

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
German Diabetes Center 2,000
Testing effectiveness (Phase 2)WithdrawnNCT01322321
What this trial is testing

ACZ885 in Type 1 Diabetes Mellitus

Who this might be right for
Diabetes MellitusDiabetes Type 1
Novartis Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Early research (Phase 1)Study completedNCT06057454
What this trial is testing

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesType 1 Diabetes (Juvenile Onset)Diabetes Mellitus, Type 1
Rise Therapeutics LLC 9
Large-scale testing (Phase 3)Study completedNCT03875729
What this trial is testing

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Who this might be right for
Type 1 Diabetes Mellitus
Provention Bio, Inc. 328
Testing effectiveness (Phase 2)Study completedNCT00024518
What this trial is testing

Interferon-Alpha for Diabetes Mellitus Type 1

Who this might be right for
Insulin-Dependent Diabetes Mellitus
The University of Texas Health Science Center, Houston 57
Not applicableStudy completedNCT04336969
What this trial is testing

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study

Who this might be right for
Type1diabetes
Stanford University 316
Not applicableEnded earlyNCT06414824
What this trial is testing

The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Jagiellonian University 28
Large-scale testing (Phase 3)Ended earlyNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Large-scale testing (Phase 3)Study completedNCT00615264
What this trial is testing

Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

Who this might be right for
Type 1 Diabetes
Andromeda Biotech Ltd. 457
Not applicableUnknownNCT04968171
What this trial is testing

Diabetes Type 1 and Fitness.

Who this might be right for
Diabetes Mellitus
Poznan University of Medical Sciences 100
Testing effectiveness (Phase 2)Ended earlyNCT00515099
What this trial is testing

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Who this might be right for
New-onset Type 1 Diabetes Mellitus
National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)Ended earlyNCT02044848
What this trial is testing

Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Study completedNCT00645840
What this trial is testing

Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT01322789
What this trial is testing

Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
University of Sao Paulo 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation